Physician profile
Robert Baker
NPI 1568425239
$2,541.37
in general payments reported to CMS, 2019-2025
10 companies · $6.28 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $134 · 2023: $997 · 2024: $1,404 · 2025: $6.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,943 · Travel and Lodging: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,943.19 |
| Travel and Lodging | $464.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,042.62 | 2022-2024 | Intracept, Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Abbvie INC. | $609.56 | 2022-2024 | |
| Spr Therapeutics, INC | $445.78 | 2024 | Sprint Pns System |
| Painteq LLC | $216.51 | 2022-2023 | Painteq |
| Collegium Pharmaceutical, INC. | $89.60 | 2023-2024 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.52 | 2023-2024 | Relistor |
| Pfizer INC. | $42.81 | 2023 | |
| Alexion Pharmaceuticals, INC. | $23.13 | 2023 | Soliris |
| Scilex Pharmaceuticals INC. | $20.56 | 2022 | |
| Electronic Waveform Lab, INC. | $6.28 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.